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Abstract
Background: Adequate malaria diagnosis and treatment remain major difficulties in rural sub- 
Saharan Africa. These issues deserve renewed attention in the light of first-line treatment with 
expensive artemisinin-combination therapy (ACT) and changing patterns of transmission intensity. 
This study describes diagnostic and treatment practices in Mto wa Mbu, an area that used to be 
hyperendemic for malaria, but where no recent assessments of transmission intensity have been 
conducted.
Methods: Retrospective and prospective data were collected from the two major village health 
clinics. The diagnosis in prospectively collected data was confirmed by microscopy. The level of 
transmission intensity was determined by entomological assessment and by estimating sero­
conversion rates using anti-malarial antibody responses.
Results: Malaria transmission intensity by serological assessment was equivalent to < l infectious 
bites per person per year. Despite low transmission intensity, > 40% of outpatients attending the 
clinics in 2006-2007 were diagnosed with malaria. Prospective data demonstrated a very high 
overdiagnosis of malaria. Microscopy was unreliable with < l%  of slides regarded as malaria 
parasite-positive by clinic microscopists being confirmed by trained research microscopists. In 
addition, many 'slide negatives' received anti-malarial treatment. As a result, 99.6% (248/249) of the 
individuals who were treated with ACT were in fact free of malaria parasites.
Conclusion: Transmission intensity has dropped considerably in the area of Mto wa Mbu. Despite 
this, most fevers are still regarded and treated as malaria, thereby ignoring true causes of febrile 
illness and over-prescribing ACT. The discrepancy between the perceived and actual level of 
transmission intensity may be present in many areas in sub-Saharan Africa and calls for greater 
efforts in defining levels of transmission on a local scale to help rational drug-prescribing behaviour.
Open Access
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Background
Adequate diagnosis and prom pt treatment of malaria 
remain major difficulties in rural settings in sub-Saharan 
Africa. In these areas, more than 70% of individuals with 
symptoms suggestive of malaria treat fevers with anti- 
malarial drugs without visiting the formal health sector 
for diagnosis [ 1,2]. If people do visit a health facility, an 
accurate diagnosis is not guaranteed. Microscopic exami­
nation of a blood smear is the gold standard m ethod for 
the diagnosis of malaria, but is often unavailable at sub­
district facilities [3]. In the absence of microscopy, malaria 
diagnosis is based on clinical symptoms that are known to 
lack specificity [4], or treatment is administered presump­
tively. Even if microscopy is available, there is substantial 
overdiagnosis of malaria [5]. There is an urgent need to 
review these diagnostic and treatment practices with the 
wide-scale implementation of the relatively expensive 
artemisinin-combination therapy (ACT) and in the light 
of changing patterns of malaria transmission.
Presumptive treatment of malaria remains a useful tool 
for malaria control in areas where malaria is common, the 
risk of progression to severe malaria is significant, and 
diagnostic facilities are lacking. In these areas, presump­
tive treatment is an effective strategy to increase the cover­
age of anti-malarials and may act to reduce transmission 
of malaria [6]. However, the strategy may not be justifia­
ble for low endemic areas where the majority of febrile 
episodes are not due to malaria [7] and over-diagnosis 
and over-treatment of malaria are very common [4,8,9]. 
Knowledge of malaria transmission intensity can guide 
clinicians in defining algorithms for dealing with febrile 
patients. However, reliable estimates of malaria transmis­
sion intensity are frequently unavailable and transmission 
intensity can change over time as a result of interventions 
[10,11] or natural fluctuations [12]. Across the African 
continent, there are reports of recent reductions in malaria 
transmission intensity (reviewed in [6]).
Investigating how rural health systems function in the cur­
rent climate of changing transmission and efforts to con­
trol and eliminate malaria seems pertinent. Here, 
diagnostic and treatment practices in rural health centres 
in Mto wa Mbu are described, an area that was historically 
hyperendemic for malaria [13], bu t where no recent 
assessments of transmission intensity have been con­
ducted.
Methods 
Study site
This study was conducted in Mto wa Mbu (latitude 3° 
21'S; longitude 35° 51' E), which is translated from 
Kiswahili as 'River of Mosquitoes'. The town is located in 
the northern highlands of Tanzania at an altitude of 960 
m -  1478 m above sea level and rain fall is largely
restricted to the short (Oct-Nov) and long rainy season 
(March-July). According to a national census that was 
conducted in 2002, the town has 16,068 inhabitants. Ret­
rospective and prospective data were collected from the 
two major village health clinics: the clinic of the Evangel­
ical Lutheran Church (KKKT) and the Roman Catholic 
Health Facility (RCHF).
Retrospective data
Both clinics routinely used microscopy for diagnosing 
malaria and reported malaria to be their primary diagno­
sis in  outpatients. Retrospective data consisted of infor­
m ation from outpatient registers of the years 2006 and 
2007. For each individual that presented at the clinic the 
visit date, age and sex was recorded, as well as if they were 
diagnosed with malaria (either by clinical assessment or 
after detection of parasites by the clinic microscopist) and 
whether anti-malarial treatment was given. Climatic data 
were obtained from the nearby Lake Manyara National 
Park.
Prospective data
Data was prospectively gathered from all individuals 
attending the clinics as patients in the months May- 
August 2007, at the end of the long rains when a high 
num ber of malaria cases was expected [12,14]. All 
patients were informed about the purpose of the study 
and asked to give written consent before inclusion in the 
study. Once enrolled, a brief questionnaire was adminis­
tered to collect information on: age, sex, bed net use, use 
of antibiotics or anti-malarials in the previous two weeks 
and symptoms. A single finger prick blood sample was 
taken for serum collection on W hatman 3 MM filter paper 
[Whatman, Maidstone, UK]. If individuals were referred 
for malaria diagnosis, a finger prick blood sample was 
taken for malaria parasite detection by Rapid Diagnostic 
Test (RDT) and two blood slides. ParaHIT® RDTs [Span 
Diagnostics Ltd, Surat, India]. RDTs were used according 
to the manufacturer's instructions and were based on the 
detection of Histidine Rich Protein 2. The first of the two 
blood slides was stained at the clinic according to the 
clinic's routine practice and scored by the microscopist 
working at the clinic. This slide result and the RDT result 
were made available to the clinician for diagnosis. The sec­
ond slide was later stained in  a research lab and read by 
two experienced research-microscopists. Parasite density 
per 200 white blood cells was determined on the thick 
smear and the slide was considered negative if no parasite 
was observed in 100 microscopic fields. Results of the two 
research microscopists were compared for validation and 
all discordant were read by a third microscopist.
Individuals who were diagnosed with malaria by the clini­
cian received artemether-lumefantrine in  line with the 
Tanzanian national policy. This study received ethical
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clearance from the ethical board of the Kilimanjaro Chris­
tian Medical Centre (KCMC Ethical Clearance certificate
2007 #167).
Entomology
Mosquitoes were collected in 10 houses that were selected 
to be representative of the different housing structures in 
the village. Mosquitoes were caught with a standard Cen­
tre for Disease Control light traps (CDC, Atlanta, GA, 
USA) every fortnight for three months (May -  September 
2007). Traps were hung at the end of an occupied bed 
with an untreated bed net that was newly provided by the 
investigators. Traps were set for 12 hours, from 7 pm to 7 
am [15,16]. In the morning, traps were collected and mos­
quito species determined and counted. Male Anopheles 
mosquitoes, Culicines and non-vector Anophelines were 
discarded. Female Anopheles mosquitoes were stored on 
silica gel for circumsporozoite protein (CSP) ELISA as 
described by Wirtz et al [17]. The head and thorax were 
removed for every mosquito, prepared for ELISA [17] and 
stored in an uncoated 96-well microtitre plate until the 
assays were performed. Samples were prepared individu­
ally and assayed with positive mosquitoes repeated. Insec­
tary reared unfed female Anophelines were used as 
negative controls together with a commercially provided 
CSP positive control [CDC, Atlanta, USA]. Samples were 
read by eye and on an ELISA plate reader at 495 nm. The 
EIR and confidence intervals were calculated as described 
by Drakeley et al. [18]. A conversion factor was used to 
adjust for the difference between light trap catches and 
m an biting catches, giving the formula: infectious bites 
per person per m onth = 1.605 * (number of positive mos­
quitoes/number of traps) * 30 [18].
MSP-I ELISA
Serum was eluted from filter papers as described by Cor­
ran et al [19]. Immunoglobulin G antibodies against 
blood stage antigens were detected by indirect ELISA, as 
previously described [20] using recombinant MSP-119 
(Wellcome genotype), which were produced as described 
previously [21]. Briefly, flat bottom  96-well plates [Immu- 
lon 4HBX, Thermo] were coated overnight with 50 |iL of 
0.5 mg/mL dilution of the specific antigen. After washing 
with PBS-0.05% Tween [(PBS-T), 200 |iL of blocking 
buffer (1% skimmed milk in PBS-T) was added for 3 
hours at room temperature. After washing, plasma sam­
ples were added in duplicate at a single dilution o f 1/1000 
and incubated at 4°C overnight. 100 |iL of rabbit anti­
hum an IgG HRP Conjugate [Dako, Ely, UK] was added 
and incubated for 1 hour at room temperature. Plates 
were developed with o-phenyline-diamine [Sigma]-H2O2 
and the reaction was stopped with 50 |iL H2SO4. Plates 
were read at 490 nm. To generate an OD cut-off value 
above which samples were deemed antibody positive, the 
distribution of OD values was fitted as the sum of two
Gaussian distributions (assuming a narrow distribution 
of seronegatives and a broader distribution of seroposi­
tives) using maximum likelihood methods [19].
Data analysis
Statistical analyses of data were performed using SPSS ver­
sion 14.0 and Stata 9.2 (Stata Corp, College Station TX, 
USA). Categorical variables were compared between 
groups by the Pearson Chi-square test or Fisher's Exact 
test, odds ratios (OR) with 95% confidence intervals 
(95% CI) were calculated. MSP-119 ELISA data were used 
to generate an age-seroprevalence plot. OD values were 
expressed as percentage of the positive control (normal­
ised OD) The annual seroconversion rate, X, and the 
annual rate of reversion to seronegativity, p, were esti­
mated by fitting a simple model of the acquisition and 
loss of antibodies to the age-specific prevalence of the 
antibodies using maximum likelihood methods assuming 
a binomial distribution [20]. The equivalent annual ento­
mological inoculation rate (EIR) was then estimated using 
a calibration curve derived from previously determined 
values [2 2 ].
Results
The perceived burden o f  malaria
In the period January 2006 -  November 2007, the two 
clinics registered a total of 22,553 outpatient visits. In this 
period, 62.9% (1696/2696) of the outpatient visits of 
children below five years of age were diagnosed with and 
treated for malaria at the KKKT clinic, compared to 39.2% 
(3284/8382) in individuals > 5 years. In the RCHF, these 
figures were 42.9% (1914/4466) and 42.1% (2948/ 
7009), respectively. There was no evident seasonal pattern 
in the total num ber of malaria cases while clear peaks in 
rainfall were recorded in the months of March-June and 
October-December (Figure 1). Total rainfall was 650 mm 
per annum.
The measured burden o f malaria
Malaria case management and microscopically confirmed 
parasitaemia
The clinical management of malaria cases was observed in 
the period June -  August 2007 at both clinics. In the KKKT 
clinic, 240 individuals attended the clinic with symptoms 
that the clinician interpreted as suggestive of malaria (Fig­
ure 2); in the RC clinic this num ber was 88 (Figure 3). 
Reported complaints, age and socio-demographic factors 
were similar between the two clinics. The m ost commonly 
reported complaint was fever (80.9%, 263/325) followed 
by respiratory complaints (41.8%, 136/325). The median 
age of suspected malaria cases was 26.5 years (IQR 10.0 -  
38.0) and 51.5% (168/326) reported the use of anti- 
malarials in the two weeks preceding their visit. Bed net 
use was reported by 85.1% (417/490) of the individuals 
without information on (recent) impregnation.
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2006 2007
Figure 1
Rainfall distribution and num ber of outpatient visits diagnosed w ith  malaria. Bars indicate the number of clinically 
diagnosed malaria patients younger than five years of age (closed bars) or > 5 years of age (open bars) in the KKKT and RCHF 
clinics combined in the period January 2006 - November 2007. The dashed line indicates the total monthly rainfall in mm/ 
month measured at the nearby Lake Manyara National Park.
Slide and RDT results and the prescribed anti-malarial 
treatment were summarized in Figures 2 and 3. A slide was 
requested for almost all individuals with suspected 
malaria (99.3% (326/328); the remaining two received 
anti-malarials without laboratory testing. All individuals 
who had parasites on their blood slide according to the 
clinic microscopist received anti-malarial treatment, both 
at the KKKT clinic and the RC clinic. O f those who were 
considered parasite free by the clinic microscopist, 58.7% 
(88/150) and 59.5% (22/37), nevertheless received anti- 
malarials at the KKKT and RC clinic, respectively. At the 
KKKT clinic 37.2% (89/239) of all requested slides were 
scored positive by the microscopist but only one of these 
'positive slides' was confirmed by the research micro­
scopists. The proportion of 'positive slides' was even 
higher in the RC clinic where 57.5% (50/87) of all 
requested slides was considered positive by the clinic 
microscopist and none of these were positive when 
stained and read by the research microscopists. One para­
site positive slide was missed by the microscopist in the 
KKKT clinic (parasite density: 27,760 parasites/^L) and 
was also RDT negative; this person received antibiotics, 
but no anti-malarials. There was no statistically significant 
association between slide positivity by the clinic micro- 
scopists and the research microscopists (p = 0.84). Ten
individuals were positive by RDT, one of them was also 
slide positive and two others reported the previous use of 
anti-malarials.
When data of the two clinics were combined, the follow­
ing factors were associated to prescription of anti-malarial 
drugs: the chance of receiving anti-malarials was increased 
when the slide was scored positive by the clinic micro- 
scopist (OR 1.70; 95% CI 1.51-1.92) and decreased in 
case of reported cough (OR 0.50 95% CI 0.30 -  0.84). 
Reported fever and reported previous use of anti-malarials 
or antibiotics were not associated with the chance of 
receiving anti-malarials at the clinic.
The entomological inoculation rate by mosquito sampling 
A total of 70 CDC light traps were set in the period May- 
September 2007. Of the mosquitoes caught, 15.6% (331/ 
2774) were of the Anopheles genus and 261 were female. 
All female mosquitoes were processed and included in the 
CSP ELISA, one was CS positive. This resulted in an esti­
mated entomological inoculation rate (EIR) of 0.69 (95% 
CI 0.02 -  3.83) infectious bites per person per m onth for 
the period surveyed.
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Figure2
Managem ent of individuals w ith suspected m alaria at the K K K T  clinic. Clinic slide = slide stained and read by clinic 
microscopist; research slide = slide stained and read by trained research microscopist; RDT = rapid diagnostic test
The entomological inoculation rate equivalent generated from 
seroprevalence data
A total of 464 serum samples were tested in the MSP119 
ELISA. The overall seroprevalence of MSP119 antibodies 
was 29.5% (137/464) and there was a clear increase in 
seroprevalence with age (Figure 4). Based on the fitted 
curve, the X was estimated at 0.026 (95% CI 0.016 -  
0.042), which corresponds to an estimated EIR of 0.70 
(0.26 -  1.87) infectious bites per person per year.
Discussion
In the study area of Mto wa Mbu that is characterised by 
low transmission intensity, an unrealistically high per­
ceived burden of malaria was observed. Forty percent of 
outpatients were treated for malaria while this diagnosis 
was not supported by blood slide or rapid test and was 
improbable in the light of the actual level of transmission 
intensity.
The level of malaria transmission intensity, as determined 
by rapid entomological assessment and MSP-119 age-sero- 
prevalence data [20], was low in the area of Mto wa Mbu. 
The EIR estimate by entomological assessment was 0.7 
infectious bites per person per month. This estimate was
obtained in the period after the long rains and probably 
represents the peak exposure to infected mosquitoes. It is, 
therefore, not surprising that it exceeds the EIR estimate 
based on the MSP119 age-seroprevalence curve (0.7 infec­
tious bites per person per year) although the confidence 
intervals for both methods overlap. In general, EIR by 
entomological assessments is susceptible to seasonal fluc­
tuations [1 2 ], fluctuations that are smoothened out by the 
immunologic assessment [20,2 2 ] that may, therefore, give 
a more robust estimate. Either m ethod will lead to the 
conclusion that transmission intensity in Mto wa Mbu is 
low. This is in contrast with cross-sectional surveys from 
1981 [13], when parasitological surveys indicated that the 
area was having a level of transmission intensity 'certainly 
equal to and probably higher than that found in Muheza- 
Ubembe' [13], an area that is still known to be hyperen­
demic for malaria [23]. Malaria transmission intensity 
clearly decreased in last 25 years but the period in which 
the reduction took place is unclear. (Recent) reductions in 
transmission intensity can be detected in age seropreva- 
lence curves when the force of infection (X) is allowed to 
change over time [22]. However, a variable X did not 
improve the fit of our curve (data not shown), and we 
found no indications for a recent reduction in EIR. Similar
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Figure3
Managem ent of individuals w ith suspected m alaria the R C H F  clinic. Clinic slide = slide stained and read by clinic 
microscopist; research slide = slide stained and read by trained research microscopist; RDT = rapid diagnostic test
to its timing, the reasons for the reduction in EIR are 
unclear. The use of chloroquinized salt can not explain 
this since it was used in the 1960s and 70s and parasite 
rates of 50-60%  in children < 10 years of age were still 
reported in 1981 [13]. Bed net coverage was high in the 
study area, but the coverage with ITNs has only increased 
in recent years [24] and also provides no plausible expla­
nation. Similar to other areas in Africa [6], the drop in 
transmission intensity is not easily explainable. The high 
use of anti-malarials for any fever treatment, as dem on­
strated in this study, could have acted as mass prophylaxis 
and reduced transmission over time [6], bu t this cannot 
be proven.
Despite the low transmission intensity in the area of Mto 
wa Mbu, more than forty percent of all outpatients who 
attended two major clinics over a period of almost two 
years were diagnosed with malaria. There was no seasonal 
pattern in malaria diagnoses, as is commonly observed 
[12,14]. Prospective data from more than 400 suspected 
malaria cases demonstrate that there was a massive over­
diagnosis of malaria in the two clinics. Despite the availa­
bility of microscopes, experienced microscopists and 
clinicians, who frequently requested slides, the targeting
of anti-malarials appeared to be unimproved [5,25]. One 
major explanation for this was that slide readings were 
unreliable in the clinics included in this study: less than 
1 % of slides that were regarded as malaria parasite-posi­
tive by clinic microscopists were confirmed by trained 
research microscopists. In addition, clinicians appeared to 
use blood slide results more as a tool to confirm their clin­
ical suspicion rather than to rule out malaria [25]. All 
individuals with 'positive slides' received anti-malarial 
treatment although a 'negative slide' did by no means rule 
out treatment [9]. This could be a result of the deeply 
entrenched belief in  slide negative malaria. It is true that 
clinical malaria can result from low density parasitaemia 
in  low endemic areas and malaria can therefore not 
always be ruled out in slide-negative cases [4]. However, 
these are exceptional cases and restricting anti-malarials to 
true microscopy-positives is a safe approach, even in  areas 
of low endemicity [8]. The prescription of anti-malarials 
in Mto wa Mbu was clearly out of proportion. An astound­
ing 99.6% (248/249) of the individuals who were treated 
with artemether-lumefantrine (AL) was free of malaria 
parasites.
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Figure 4
Age specific seroprevalence plot of anti-MSP-1 !9 anti­
bodies. The vertical axis shows the proportion of seroposi­
tive individuals in each age group, the horizontal axis shows 
the midpoint age of each age group. Filled triangles represent 
the raw data; the lines represent the fitted equation with 
parameters X = 0.026 and p = 0.026 and the 95% confidence 
interval.
Although a recently published hypothesis suggests that 
overdiagnosis and overtreatment of malaria can have a 
beneficial prophylactic effect in malaria control [6], the 
current findings are worrying for several reasons. Firstly, 
our area is of low endemicity and a beneficial prophylactic 
effect is unlikely [6]. Secondly, diagnosis of malaria and 
according treatment may simply be a 'convenient' clinical 
strategy avoiding the more complicated search for other 
causes of the presenting illness [25]. Treatment of all 
febrile episodes as malaria is likely to result in  underdiag­
nosis of other fever-causing disorders such as childhood 
pneum onia [2]. Thirdly, over-treatment occurred with the 
expensive AL. AL and other ACTs are typically 10-times 
more expensive then previously used drugs as sulphadox- 
ine-pyrimethamine [26,27] making reliable diagnosis cru­
cial for cost-effective use [28]. The artemisinin component 
in  ACT also do not have the prophylactic effect that was 
suggested to be beneficial in  'opportunistic presumptive 
treatment' [6]. Artemisinin is eliminated from the circula­
tion in a matter of hours [29] leaving the partner drug, in 
this case lumefantrine, unprotected. That leads us to the 
fourth reason for unease. There is concern for a reduced 
susceptibility of P. falciparum parasites for ACT [29] and 
the spread of parasites with reduced susceptibility to ACT 
may be enhanced by irrational drug use [30]. Reports on 
allelic selection after artemether-lumefantrine [31] pro­
vide additional warnings against over-use of ACT.
For a way forward, it is important to understand why there 
is so much overdiagnosis and overtreatment in  the study 
area. A recent study elsewhere in  Tanzania has dem on­
strated that patient pressure, traditionally mentioned as a
major contributor [32], may not be im portant in over­
treatment [33]. Patients often prefer to be slide-tested and 
treated in line with results [33]. In the clinics in Mto wa 
Mbu, slide reading was clearly inadequate. Microscopists 
will need additional training and in addition, more objec­
tive diagnostic tools such as RDTs can play a role in the 
improvement of diagnosis. Clinicians in this study felt 
uncomfortable to rule out malaria based on a negative 
RDT (and one patient in our study was in fact a false RDT 
negative). Time will be needed to make them consider 
RDTs as useful diagnostic tools [34]. Perhaps delivering a 
message to health workers and the public explaining that 
malaria control has been successful in some areas and 
malaria has truly been reduced may improve the situa­
tion. If both health staff and public understand that this 
fever may not be due to malaria quality of care may 
improve and "routine overdiagnosis" may be a story of 
the past.
Conclusion
The observed discrepancy between the perceived and 
actual level of transmission intensity may be present in 
many areas in sub-Saharan Africa and calls for greater 
efforts in defining levels of transmission on a local scale. 
National policies may have to give way to more sensible 
local policies that use proven multiple interventions in 
areas of high-moderate transmission and focus on accu­
rate diagnosis and treatment in low transmission settings.
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